You are seeing these quotes based on previous browsing related to sectors such as
Latest | Forecast | |
---|---|---|
Div Yield | 0.0% | n/a |
Div Cover | n/a | n/a |
Op Mrgn | 0.0% | n/a |
ROCE | 0.0% |
Latest | Forecast | |
---|---|---|
P/E | -1.2 | n/a |
PEG | 0.0 | n/a |
Price / Revenue | 0.0 | n/a |
Price / Book value | 0.9 |
Latest | Forecast | |
---|---|---|
Revenue | n/a | 0.0% |
PBT | 0.0% | n/a |
EPS | 0.0% | 0.0% |
DPS | n/a | 0.0% |
Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
---|---|---|---|---|---|---|---|---|
2019-12-31 | n/a | -0.95 | -0.87p | -3.2 | 0.0 | n/a | n/a | 0.0% |
2020-12-31 | n/a | -1.57 | -0.96p | -8.7 | 0.0 | n/a | n/a | 0.0% |
2021-12-31 | n/a | -1.84 | -0.85p | -5.2 | 0.0 | n/a | n/a | 0.0% |
2022-12-31 | n/a | -1.19 | -0.55p | -3.4 | 0.0 | n/a | n/a | 0.0% |
N4 Pharma shares jump on latest Nuvec developments Sharecast News | 15 Feb |
---|---|
N4 Pharma's Nuvec granted patent in India Sharecast News | 19 Jan |
N4 Pharma subsidiary agrees work programme for glaucoma treatment Sharecast News | 16 Jan |
Holding(s) in Company | 04-Mar-24 15:15 |
---|---|
Holding(s) in Company | 29-Feb-24 07:01 |
in-vitro siRNA update | 15-Feb-24 07:00 |
Patent Grant | 19-Jan-24 07:00 |
Holding(s) in Company | 18-Jan-24 10:15 |